Martial G Bourassa. Show Affiliations »
Abstract
Entities: Disease Gene
Mesh： See more » Adrenergic beta-Antagonists/therapeutic useAgedAngiotensin II Type 1 Receptor Blockers/therapeutic useAntihypertensive Agents/therapeutic useAtenolol/therapeutic useAtrial Fibrillation/mortalityAtrial Fibrillation/prevention & controlCause of DeathDouble-Blind MethodElectrocardiography/drug effectsFemaleHumansHypertension/drug therapyHypertension/mortalityLosartan/therapeutic useMaleMiddle AgedMyocardial Infarction/mortalityMyocardial Infarction/prevention & controlProspective StudiesRandomized Controlled Trials as TopicStroke/mortalityStroke/prevention & controlSurvival Rate
Substances： See more » Adrenergic beta-AntagonistsAngiotensin II Type 1 Receptor BlockersAntihypertensive AgentsAtenololLosartan
Year: 2005 PMID： 15734616 DOI： 10.1016/j.jacc.2004.12.008
Source DB: PubMed Journal: J Am Coll Cardiol ISSN： 0735-1097 Impact factor: 24.094